As of Thursday, July 02, Caribou Biosciences, Inc.’s CRBU share price has surged by 7.16%, which has investors questioning if this is right time to sell.

The human-made cells show many hallmarks of life, but they can't make all their necessary internal structures or divide for ...

Scientists at the University of Minnesota say they've made the first synthetic cell that can complete a life cycle, a major ...

What makes something alive? We simply don't know, but synthetic biologists are a step closer to providing an answer thanks to ...

A super-resolution image of SpudCell’s liposomes with an encapsulated genome and active protein expression. Photograph: Orion Venero/Adamala Lab A tiny blob in a dish has pushed one of biology’s ...

German researchers hit a record 31.3% efficiency converting sunlight directly to hydrogen, a breakthrough that could ease green hydrogen's cost problem.

Orca-T integrates HSPCs for reconstitution, highly purified Tregs for GVHD suppression, and Tcons to accelerate immune recovery and preserve graft-versus-leukemia activity via a matched-donor, patient ...

A substantial proportion of patients with apparently isolated giant cell arteritis may also have subclinical polymyalgia rheumatica, with distinct disease patterns.

New Georgia laws taking effect July 1 will impact cellphones in schools, medical cannabis rules, paid maternal leave and more ...

With insights from 30+ expert leaders and networking opportunities with top pharma and biotech innovators, this guide will help you stay ahead in the rapidly evolving allogeneic landscape. Download ...

Platinum-resistant high-grade serous ovarian carcinomas (HGSOC) are associated with poor therapeutic outcomes. Although HGSOC frequently metastasizes to the intraperitoneal (IP) cavity, the success of ...

Immune effector cell-associated neurotoxicity syndrome (ICANS) is a severe complication of CAR T-cell therapy. Although CAR T-cells have been detected in cerebrospinal fluid (CSF), their viability ...